Elevating a Rich Oncology Community: SITC’s DEI Strategic Plan

Elevating a Rich Oncology Community: SITC’s DEI Strategic Plan

SITC formed the Diversity, Equity & Inclusion Task Force to help set the strategic direction for the society on its diversity, equity and inclusion efforts. We aim to improve opportunities for research, education, and professional development that promote diversity, equity, and inclusion within the society and field of cancer immunotherapy.

Plan GoalsPlan FocusEarly CareerLeadershipClinical TrialsPatient Access Task ForceWatch the Latest DEI Panels

Watch the latest panel, “Barriers to Black and African Americans in Science and Medicine Diversity Panel." This is an hour-long group discussion featuring society leaders who share personal and professional reflections as Black and African Americans working in science and medicine in the United States.

Diversity, Equity and Inclusion Strategic Plan Goals

Membership Engagement

Recruit, retain and foster a diverse community of domestic and international members.

Research

Breakdown barriers to diversity, equity, and inclusion in the broader cancer immunotherapy research community.

Education

Increase diversity of the immuno-oncology workforce and educate the community on diversity, equity and inclusion issues.

Professional Development

Represent diverse backgrounds and experiences within all society funding, speaking, volunteer and training opportunities.

Patient Care & Clinical Trials

Understand and address the barriers and needs of SITC members in clinical practice, and advocate for equitable patient access, domestically and globally.

Diversity, Equity and Inclusion Task Force

Avatar

Chair
Leisha A. Emens, MD, PhD

UPMC Hillman Cancer Center

Avatar

Co-Chair
Adekunle Odunsi, MD, PhD

University of Chicago Medicine Comprehensive Cancer Center

Avatar

Ghassan K. Abou-Alfa, MD, MBA
Memorial Sloan Kettering Cancer Center

Avatar

Ana Carrizosa Anderson, PhD
Harvard Medical School

Avatar

Tullia C. Bruno, PhD
University of Pittsburgh

Avatar

Charlie T. Garnett-Benson, PhD
Bristol Myers Squibb

Avatar

Chelsea Pinnix, MD, PhD
The University of Texas MD Anderson Cancer Center

Avatar

Avery D. Posey, Jr., PhD
University of Pennsylvania School of Medicine


Diversity in Clinical Trials

One of the five goals outlined by the SITC Diversity, Equity and Inclusion Task Force’s 2022-2024 strategic plan focuses on patient care and clinical trials, specifically with regard to enhancing diversity in clinical trial enrollment. To accomplish this goal, the Task Force aims to facilitate a conversation to frame the overall strategy and issues related to enrollment and diversity in clinical trials, and outline actions/next steps for how SITC may be able to aid the community.

SITC leadership has heard from Industry about the challenges and need for clarification surrounding the implementation of the FDA Guidance on diversity in clinical trial enrollment, entitled “Diversity Plans to Improve Enrollment of Participants From Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft Guidance for Industry; Availability.”

Corporate Member Roundtable
The DEI Task Force will host a Corporate Member Roundtable with key stakeholders including Industry (pharmaceutical and biotech companies), the FDA and SITC leadership to discuss the FDA Guidance on diversity in clinical trial enrollment, elucidate questions and challenges key stakeholders have in implementing the guidance, and facilitate a conversation with these key stakeholders to provide clarity and direction.

DEI Strategic Plan Focus

Research & Patient Access

Clinical Trial Diversity and Equitable Patient Access


Landscape Analysis >

Collaborate >

Crisis in Clinical Research >

Workforce Pipeline: New Early Career Scientist Efforts

STEM Undergrad Program for URMs

  • 1-day, curated program at Annual Meeting
  • First program at SITC 2022
  • Watch Preview >

Travel Awards for Underrepresented Minorities

  • For ECS
  • For all SITC programs

DEI Fellowships

  • DEI and Women Fellowships
  • Goal: Offer Annually

Educational Programs at HBCUs

  • Educational programs at historically black and Hispanic colleges and universities
  • Long Term Goal

Workforce Pipeline: Existing Early Career Scientist Efforts

Women in Immunotherapy Network (WIN) Leadership Institute

Sparkathon

Hybrid and Virtual Programs Increase Access

Membership and Registration Discounts

  • LMICs
  • Financial Hardships

Workforce Pipeline: Leadership

Mentorship Program

  • Partner a senior leader with an early career person during the Annual Meeting to extend longitudinally

DEI Positioned Purposefully

  • Collecting race/ethnicity data
  • Website section to feature diverse membership
  • Global diversity
  • Landscape analyses

Diversity in SITC Faculty, Committees, Board

  • Ensure diverse slate of speakers, committee members, and election candidates

Listening Sessions & Diversity Panels

  • 2021: Asian and Pacific Islander
  • 2022: Black and African American

Clinical Trial Diversity and Equitable Patient Access

Landscape Analysis

  • Professional societies, government agencies, Industry; to ensure a lack of duplicity and find gaps in clinically oriented DEI programs
  • Long Term

Collaborate

  • With like-minded stakeholders in academic, NIH/NCI, FDA, pharma based on outputs related to patient care/clinical trials
  • Long Term

Crisis in Clinical Research

  • Partner/parallel work with outputs stemming from August 17 Summit

Watch Our Latest DEI Panels